An archaeosome-adjuvanted vaccine and checkpoint inhibitor therapy combination significantly enhances protection from murine melanoma

Download
  1. (PDF, 795 KB)
  2. Get@NRC: An archaeosome-adjuvanted vaccine and checkpoint inhibitor therapy combination significantly enhances protection from murine melanoma (Opens in a new window)
DOIResolve DOI: http://doi.org/10.3390/vaccines5040038
AuthorSearch for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for:
TypeArticle
Journal titleVaccines
ISSN2076-393X
Volume5
Issue4
Pages# of pages: 16
Subjectcheckpoint inhibitor; PD-1; CTLA-4; tumor-infiltrating lymphocyte (TIL); cancer vaccine; CD8+ T cell response; archaeosome; prime-boost; B16; liposome; tumor vaccine; effector T cell (TE); effector memory T cell (TEM)
Abstract
Publication date
PublisherMDOI
LanguageEnglish
AffiliationHuman Health Therapeutics; National Research Council Canada
Peer reviewedYes
NPARC number23002442
Export citationExport as RIS
Report a correctionReport a correction
Record identifier1ff8f5a6-aba3-4909-bfa7-97e7093a9083
Record created2017-11-10
Record modified2017-11-10
Bookmark and share
  • Share this page with Facebook (Opens in a new window)
  • Share this page with Twitter (Opens in a new window)
  • Share this page with Google+ (Opens in a new window)
Date modified: